Copart, Inc. CPRT
27.59
(0.45)
(1.60%)
as of 25 Sep
- Market cap
- $26.1B
- P/E
- 17.7×
Follow CPRT
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Copart, Inc. (CPRT) Revenue growth
Copart, Inc.'s revenue growth over the twelve months to 31 July 2026 was 0.41%. Over the past ten years it has ranged from −1.50% (fiscal 2015) to 30.0% (fiscal 2022); the current reading is higher than 17% of that period. That is below the Specialty Business Services industry median of 6.04% and below the Industrials sector median of 7.96%.
Revenue growth, annual
Annual
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2026 | 0.41% | (9.27) |
| FY2025 | 9.68% | 0.19 |
| FY2024 | 9.49% | (1.04) |
| FY2023 | 10.5% | (19.49) |
| FY2022 | 30.0% | 7.94 |
| FY2021 | 22.1% | 14.07 |
| FY2020 | 8.01% | (5.07) |
| FY2019 | 13.1% | (11.62) |
| FY2018 | 24.7% | 10.55 |
| FY2017 | 14.2% | 3.47 |
Quarterly
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jul 2026 | 2.43% | 0.34 |
| Apr 2026 | 2.09% | 5.67 |
| Jan 2026 | −3.58% | (4.30) |
| Oct 2025 | 0.72% | (4.53) |
| 43 more quarters | Free account |
Against its own ten years
Low −1.50%
High 30.0%
Ten-year median
10.6%
Current reading's percentile
17
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| AMTM Amentum Holdings, Inc. compare | 11.4% |
| ARMK Aramark compare | 11.0% |
| RELX RELX PLC compare | 10.3% |
| CTAS Cintas Corporation compare | 9.51% |
| ULS UL Solutions Inc. compare | 6.61% |
| UNF Unifirst Corporation compare | 1.42% |
| DLB Dolby Laboratories compare | 0.55% |
| CPRT Copart, Inc. | 0.41% |
| RTO Rentokil Initial PLC compare | — |
| Specialty Business Services industry median | 6.04% |
| Industrials sector median | 7.96% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on CPRT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- The full statement